Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Water Purification for Developing Countries
Each year, more than 3.5 million people die from lack of access to clean water in developing countries. Our...
DNA to the rescue: A first genetic approach for the conservation of the endangered great green macaw
The beautiful, yet endangered, great green macaw faces the loss of its habitat and the illegal pet trade. The...
